Abstract
Aging manifests as progressive deterioration in cellular and systemic homeostasis, requiring systems-level perspectives to understand the gradual molecular dysregulation of underlying biological processes. Here, we report systems-level changes in the molecular regulation of biological processes under multiple lifespan-extending interventions in mice and across age in humans. In mouse cohorts, Differential Rank Conservation (DIRAC) analyses of liver proteomics and transcriptomics show that mechanistically distinct prolongevity interventions tighten the regulation of aging-related biological modules, including fatty acid metabolism and inflammation processes. An integrated analysis of liver transcriptomics with mouse genome-scale metabolic model supports the shifts in fatty acid metabolism. Additionally, the difference in DIRAC patterns between proteins and transcripts suggests biological modules which may be tightly regulated via cap-independent translation. In a human cohort spanning the majority of the adult lifespan, DIRAC analyses of blood proteomics and metabolomics demonstrate that regulation of biological modules does not monotonically loosen with age; instead, the regulatory patterns shift according to both chronological and biological ages. Our findings highlight the power of systems-level approaches to identifying and characterizing the biological processes involved in aging and longevity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the National Institutes of Health (NIH) grant U19AG023122 awarded by the National Institute on Aging (NIA) (to S.R.C., N.J.S., R.A.M., R.L.M., and N.R.), the M.J. Murdock Charitable Trust (Reference No. 2014096:MNL:11/20/2014, awarded to N.D.P. and L.H.), and a generous gift from Carole Ellison (to K.W. and T.W.). K.W. was supported by The Uehara Memorial Foundation (Overseas Postdoctoral Fellowships).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Procedures for the current study were run under the Western Institutional Review Board (WIRB) with Institutional Review Board (IRB) Study Number 20170658 at the Institute for Systems Biology and 1178906 at Arivale (both in Seattle, WA).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
author list corrected
Data Availability
The MS data of the LC-M001 and LC-M004 proteomics have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (PXD035255). Note that this data will be available after journal publication; until then, requests should be directed to the corresponding authors. The processed data of M001-related transcriptomics was kindly provided by Vadim N. Gladyshev (Harvard Medical School), and raw data is available on the NCBI's Gene Expression Omnibus (GEO) repository (GSE131901). The Arivale datasets can be accessed by qualified researchers for research purposes. Requests should be sent to data-access@isbscience.org. The de-identified data will be available to the qualified researchers on submission and approval of a research plan.
